ADA Scientific Sessions 2025 Abstract·13 JunGenetically Determined PPARA Expression Modulates Fenofibrate Response on Lipid Profile—A Pharmacogenetic TrialTrial in peopleInterventionsPaper
Diabetologia·12 MaySGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting SystemCohort study of 2,397 peopleSGLT2 inhibitorsPaper
Nutrition, Metabolism, and Cardiovascular Diseases·24 MarMetformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trialRandomised trial in 38 peopleMetforminPaper